Teriparatide improves bone microarchitecture in postmenopausal women previously treated with alendronate

被引:0
|
作者
Li, J. [1 ]
Burr, D. B. [1 ]
Stepan, J. J. [2 ]
Dobnig, H. [3 ]
Fahrleitner-Pammer, A. [3 ]
Sipos, A. [4 ]
Mullamey, T. [4 ]
Westmore, M. [4 ]
Sato, M. [4 ]
Pavo, I. [4 ]
机构
[1] Indiana Univ, Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46204 USA
[2] Charles Univ Prague, Fac Med, Inst Rheumatol, CR-11636 Prague 1, Czech Republic
[3] Med Univ Graz, Dept Internal Med, Graz, Austria
[4] Lilly Res Labs, Indianapolis, IN USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1095
引用
收藏
页码:S28 / S28
页数:1
相关论文
共 50 条
  • [21] Differential effects of teriparatide and alendronate on bone remodeling in postmenopausal women assessed by histomorphometric parameters
    Arlot, M
    Meunier, PJ
    Boivin, G
    Haddock, L
    Tamayo, J
    Correa-Rotter, R
    Jasqui, S
    Donley, DW
    Dalsky, GP
    San Martin, J
    Eriksen, EF
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (07) : 1244 - 1253
  • [22] EFFECTS OF TERIPARATIDE ON VERTEBRAL BODY BIOMECHANICS IN POSTMENOPAUSAL WOMEN TREATED PREVIOUSLY WITH RISEDRONATE OR ALENDRONATE: A QCT-BASED FINITE ELEMENT STUDY
    Zysset, P.
    Quek, E.
    Borah, B.
    Gross, G.
    Stewart, J.
    Lang, T.
    Chevalier, Y.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 154 - 154
  • [23] Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronate
    McClung, Michael
    Recker, Robert
    Miller, Paul
    Fiske, Darrell
    Minkoff, Jerome
    Kriegman, Audrey
    Zhou, Wenchun
    Adera, Mathews
    Davis, Jenny
    [J]. BONE, 2007, 41 (01) : 122 - 128
  • [24] APPLICATION OF QUANTITATIVE BONE SCAN USING KBONE VALUES FOR THE ASSESSMENT OF REGIONAL BONE METABOLISM IN POSTMENOPAUSAL OSTEOPOROTIC WOMEN TREATED EITHER WITH ALENDRONATE OR TERIPARATIDE
    Dixit, V.
    Parida, G.
    Sen, S.
    Sati, H.
    Kumar, R.
    Malhotra, R.
    Garg, B.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S432 - S432
  • [25] Spectroscopic markers of bone quality in alendronate-treated postmenopausal women
    Boskey, A. L.
    Spevak, L.
    Weinstein, R. S.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2009, 20 (05) : 793 - 800
  • [26] Spectroscopic markers of bone quality in alendronate-treated postmenopausal women
    A. L. Boskey
    L. Spevak
    R. S. Weinstein
    [J]. Osteoporosis International, 2009, 20 : 793 - 800
  • [27] Femoral strength in osteoporotic women treated with teriparatide or alendronate
    Keaveny, Tony M.
    McClung, Michael R.
    Wan, Xiaohai
    Kopperdahl, David L.
    Mitlak, Bruce H.
    Krohn, Kelly
    [J]. BONE, 2012, 50 (01) : 165 - 170
  • [28] APPLICATION OF QUANTITATIVE BONE SCAN USING KBONE VALUES TO IDENTIFY REGIONAL BONE METABOLISM CHANGES IN POSTMENOPAUSAL OSTEOPOROTIC WOMEN TREATED EITHER WITH ALENDRONATE OR TERIPARATIDE
    Garg, B.
    Dixit, V.
    Parida, G.
    Sati, H.
    Kumar, R.
    Malhotra, R.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2020, 31 (SUPPL 1) : S610 - S611
  • [29] APPLICATION OF QUANTITATIVE BONE SCAN USING KBONE VALUES TO IDENTIFY REGIONAL BONE METABOLISM CHANGES IN POSTMENOPAUSAL OSTEOPOROTIC WOMEN TREATED EITHER WITH ALENDRONATE OR TERIPARATIDE
    Garg, B.
    Dixit, V.
    Parida, G.
    Sen, S.
    Sati, H. C.
    Kumar, R.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2018, 29 : S166 - S166
  • [30] Alendronate improves QOL of postmenopausal women with osteoporosis
    Kawate, Hisaya
    Ohnaka, Keizo
    Adachi, Masahiro
    Kono, Suminori
    Ikematsu, Hideyuki
    Matsuo, Hisashi
    Higuchi, Kazumi
    Takayama, Takehiko
    Takayanagi, Ryoichi
    [J]. CLINICAL INTERVENTIONS IN AGING, 2010, 5 : 123 - 131